Emilie Le Rhun
Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis.
Bellomo J, Zeitlberger A, Padevit L, Stumpo V, Gönel M, Fierstra J, Nierobisch N, Reimann R, Witzel I, Weller M, Le Rhun E, Bozinov O, Regli L, Neidert M, Serra C, Voglis S. Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis. J Neurooncol 2024; 169:379-390.
Jun 3, 2024Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis.
Jun 3, 2024J Neurooncol 2024; 169:379-390
Bellomo Jacopo, Zeitlberger Anna Maria, Padevit Luis, Stumpo Vittorio, Gönel Meltem, Fierstra Jorn, Nierobisch Nathalie, Reimann Regina, Witzel Isabell, Weller Michael, Le Rhun Emilie, Bozinov Oliver, Regli Luca, Neidert Marian Christoph, Serra Carlo, Voglis Stefanos
Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.
Stadler C, Gramatzki D, Le Rhun E, Hottinger A, Hundsberger T, Roelcke U, Läubli H, Hofer S, Seystahl K, Wirsching H, Weller M, Roth P. Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older. Neurooncol Pract 2023; 11:132-141.
Oct 20, 2023Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.
Oct 20, 2023Neurooncol Pract 2023; 11:132-141
Stadler Christina, Gramatzki Dorothee, Le Rhun Emilie, Hottinger Andreas Felix, Hundsberger Thomas, Roelcke Ulrich, Läubli Heinz, Hofer Silvia, Seystahl Katharina, Wirsching Hans-Georg, Weller Michael, Roth Patrick
Maximal surgical tumour load reduction in immune-checkpoint inhibitor naïve patients with melanoma brain metastases correlates with prolonged survival.
Voglis S, Schaller V, Müller T, Gönel M, Winklhofer S, Mangana J, Dummer R, Serra C, Weller M, Regli L, Le Rhun E, Neidert M. Maximal surgical tumour load reduction in immune-checkpoint inhibitor naïve patients with melanoma brain metastases correlates with prolonged survival. Eur J Cancer 2022; 175:158-168.
Sep 17, 2022Maximal surgical tumour load reduction in immune-checkpoint inhibitor naïve patients with melanoma brain metastases correlates with prolonged survival.
Sep 17, 2022Eur J Cancer 2022; 175:158-168
Voglis Stefanos, Schaller Valentina, Müller Timothy, Gönel Meltem, Winklhofer Sebastian, Mangana Joana, Dummer Reinhard, Serra Carlo, Weller Michael, Regli Luca, Le Rhun Emilie, Neidert Marian C
Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM)
Hofer S, Baumert B, Läubli H, Gramatzki D, Reinert M, Pesce G, Schucht P, Frank I, Lehnick D, Weiss T, Wirsching H, Wolpert F, Roth P, Eggenberger N, Pflugshaupt T, Keller K, Imbach L, Roelcke U, Hutter G, Hundsberger T, Hertler C, Le Rhun E, Vasella F, Cordier D, Neidert M, Hottinger A, Migliorini D, Weller M. Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM). Swiss Med Wkly 2021; 151:w20501.
May 16, 2021Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM)
May 16, 2021Swiss Med Wkly 2021; 151:w20501
Hofer Silvia, Baumert Brigitta, Läubli Heinz, Gramatzki Dorothee, Reinert Michael, Pesce Gianfranco, Schucht Philippe, Frank Irène, Lehnick Dirk, Weiss Tobias, Wirsching Hans-Georg, Wolpert Fabian, Roth Patrick, Eggenberger Noemi, Pflugshaupt Tobias, Keller Kristina, Imbach Lukas, Roelcke Ulrich, Hutter Gregor, Hundsberger Thomas, Hertler Caroline, Le Rhun Emilie, Vasella Flavio, Cordier Dominik, Neidert Marian Christoph, Hottinger Andreas, Migliorini Denis, Weller Michael
Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02
von Achenbach C, von Deimling A, Schneider H, Lawhon T, Rushing E, Neidert M, Sievers P, Wang S, Sahm F, Le Rhun E, Weller M. Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02. Transl Oncol 2020; 13:100852.
Sep 8, 2020Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02
Sep 8, 2020Transl Oncol 2020; 13:100852
von Achenbach Caroline, von Deimling Andreas, Schneider Hannah, Lawhon Tracy, Rushing Elisabeth J, Neidert Marian Christoph, Sievers Philipp, Wang Sophie S, Sahm Felix, Le Rhun Emilie, Weller Michael
Venous thromboembolic events in patients with brain metastases: the PICOS score
Wolpert F, Preusser M, Le Rhun E, Andratschke N, Neidert M, Roth P, Löb R, Lareida A, Grossenbacher B, Berghoff A, Weller M. Venous thromboembolic events in patients with brain metastases: the PICOS score. Eur J Cancer 2020; 134:75-85.
May 27, 2020Venous thromboembolic events in patients with brain metastases: the PICOS score
May 27, 2020Eur J Cancer 2020; 134:75-85
Wolpert Fabian, Preusser Matthias, Le Rhun Emilie, Andratschke Nicolaus, Neidert Marian Christoph, Roth Patrick, Löb Raphael, Lareida Anna, Grossenbacher Bettina, Berghoff Anna S, Weller Michael
Antidepressant drug use in glioblastoma patients: an epidemiological view
Gramatzki D, Rogers J, Neidert M, Hertler C, Le Rhun E, Roth P, Weller M. Antidepressant drug use in glioblastoma patients: an epidemiological view. Neurooncol Pract 2020; 7:514-521.
Apr 25, 2020Antidepressant drug use in glioblastoma patients: an epidemiological view
Apr 25, 2020Neurooncol Pract 2020; 7:514-521
Gramatzki Dorothee, Rogers James Louis, Neidert Marian Christoph, Hertler Caroline, Le Rhun Emilie, Roth Patrick, Weller Michael
Risk factors for the development of epilepsy in patients with brain metastases
Wolpert F, Le Rhun E, Imbach L, Poryazova R, Roth P, Neidert M, Grossenbacher B, Terziev R, Lareida A, Weller M. Risk factors for the development of epilepsy in patients with brain metastases. Neuro Oncol 2020; 22:718-728.
Jan 15, 2020Risk factors for the development of epilepsy in patients with brain metastases
Jan 15, 2020Neuro Oncol 2020; 22:718-728
Wolpert Fabian, Le Rhun Emilie, Imbach Lukas L, Poryazova Rositsa, Roth Patrick, Neidert Marian Christoph, Grossenbacher Bettina, Terziev Robert, Lareida Anna, Weller Michael
Diagnostic value of F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
Wolpert F, Preusser M, Kaufmann P, Reyns N, Roth P, Frauenfelder T, Dummer R, Stahel R, Stupp R, Neidert M, Regli L, Andratschke N, Leske H, Petyt G, Füreder L, Rushing E, Berghoff A, Weller M, Le Rhun E. Diagnostic value of F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site. Eur J Cancer 2018; 96:64-72.
Apr 17, 2018Diagnostic value of F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
Apr 17, 2018Eur J Cancer 2018; 96:64-72
Wolpert Fabian, Preusser Matthias, Kaufmann Philipp Antonio, Reyns Nicolas, Roth Patrick, Frauenfelder Thomas, Dummer Reinhard, Stahel Rolf, Stupp Roger, Neidert Marian Christoph, Regli Luca, Andratschke Nicolaus, Leske Henning, Petyt Gregory, Füreder Lisa Michaela, Rushing Elisabeth, Berghoff Anna Sophie, Weller Michael, Le Rhun Emilie